Press Release

                                                                                                                                             Japan Airlines Co.,Ltd.
                                                                                                                                              Marubeni Corporation
                                                                                                                                                                    MTI Ltd.
                                                                                                                                              CARADA medica Inc. 

On January 27, 2022, Japan Airlines Co., Ltd. (hereinafter " JAL "), Marubeni Corporation (hereinafter
"Marubeni"), MTI Ltd. (hereinafter "MTI") and CARADA medica Inc. (hereinafter "CARADA medica") signed a
"Joint Initiative Memorandum of Understanding" to utilize a service that provides comprehensive support to
improve health issues that are unique to women and verify the effects (hereinafter referred to as "this service"). This joint initiative (hereinafter referred to as "joint initiative") will start from February.

This service has been in joint development by Marubeni, MTI, and CARADA medica since July 2021 and is
being provided to corporations. Through the provision of online consultation, medical care services and
awareness activities in collaboration with medical institutions, this service improves menstrual pain and
premenstrual syndrome (PMS), supports fertility and fertility treatment, and improves symptoms that appear
during menopause, which working women faces as their health challenges at each life stage.

JAL recognizes that it is essential to improve the physical and mental health of employees in order to provide
the best service to customers. JAL believe that the understanding and support of the actual health issues of
female employees who are active in various workplaces, will greatly contribute to improve corporate value and
the service which we provide to the customers. In addition, JAL and Marubeni have jointly implemented such
various business activities as business jet charter services and a Sustainable Aviation Fuel (SAF) production
business in building a relationship as business partners.

Against this background, JAL has already participated as a demonstration company for this service, and has
decided to implement a program that provides seminars to deepen the understanding of menstruation, fertility, and menopause for all employees regardless of gender, and "LunaLuna Telemedicine" for female employees.

Through this joint initiative, JAL, Marubeni, MTI, and CARADA medica aim to enhance understanding and mutual support of working women’s health issues, to form a more comfortable working society, and to promote diversity and inclusion*1.

[About this joint initiative at JAL] 
<Overview>
We will conduct a fact-finding survey on women's health issues at JAL, improve literacy and change consciousness through the following seminars, build a comfortable working environment by introducing a program, and
verify its effects.

<Seminar/Introduction Program Contents>

< Period> 
February 2022 - December 2022 (planned) 
*1: Diversity and Inclusion：Adapt, accept and empower individual "differences" that occur from external differences such as race, gender, and age, as well as religion, values, personality, and preference.
*2: FEMCATIONTM : A coined word that combines FEMALE and EDUCATION.

[Image of this service]

[Overview of each company] Company name

<JAL>
Company name              : Japan Airlines Co., Ltd.
Representative               : Yuji AKASAKA, President and CEO
Headquarters location    : 2-4-11 Higashi-Shinagawa, Shinagawa-ku, Tokyo Nomura Real Estate Agency
                                         Tennozu Building, Tokyo
Website                           : https://www.jal.com/en/

<Marubeni>
Company name              : Marubeni Corporation
Representative               : Masumi KAKINOKI, President and CEO 
Headquarters location    : 4-2 Otemachi 1 Chome, Chiyoda-ku, Tokyo
Website                          : https://www.marubeni.com/en/

<MTI>
Company name             : MTI Ltd.
Representative              : Toshihiro MAETA, President and Chief Executive Officer
Headquarters location   : Tokyo Opera City Tower 35F, 3-20-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo
Website                         : https://www.mti.co.jp/eng/

<CARADA medica>
Company name            : CARADA medica Inc.
Representative             : Seitaro SUGAWARA, Representative Director
Headquarters location   : Tokyo Opera City Tower 35F, 3-20-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo
Website                         : https://caradamedica.co.jp/